- BySeeking Alpha-
1. BioNTech Biontech (NASDAQ:BNTX) was up 7.42, or 10 1/2%, on Monday, to 77.78, after reaching a session high of 84.86, on 8.5 million shares traded. In after-hours it popped...
For Immediate ReleaseChicago, IL – June 7, 2019 - Stocks in this week’s article are HP Inc. (NYSE:HPQ) , Party City Holdco Inc. (NYSE:PRTY) , AbbVie Inc....
OncoSec Medical Incorporated is a biotechnology company. The Company is focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The Company’s core platform technology, ImmunoPulse, is a drug-device therapeutic modality comprised of intratumoral electroporation (EP) delivery device. The ImmunoPulse platform is designed to deliver plasmid deoxyribonucleic acid (DNA)-encoded drugs directly into a solid tumor and promote an immunological response against cancer. The ImmunoPulse device can be adapted to treat different tumor types and consists of an electrical pulse generator, a reusable handle and disposable applicators. The Company’s lead product candidate is a DNA-encoded interleukin-12 (IL-12) called tavokinogene telseplasmid (TAVO).